New Drug Development Services
iv inoculation models
- Categories:Oncology in vivo
- Time of issue:2023-10-07 15:30:02
- Views:0
Welcome to our systemic inoculation model platform, specially designed for pre-clinical research on hematologic tumor drugs. Recognizing the uniqueness of hematologic tumors, we've developed this advanced model platform to ensure a more accurate and efficient drug evaluation and research process.
Platform Features and Applications:
• Flow Cytometry Analysis: Our platform utilizes flow cytometry technology, enabling precise detection and analysis of the quantity, activity, and drug interactions of hematologic tumor cells.
• In Vivo Fluorescence Imaging: This technology allows for real-time, non-invasive monitoring of the distribution, growth, and drug response of hematologic tumor cells in the body, providing key dynamic data for drug evaluations.
• Integration with the iHuPBMC Model: By combining with our iHuPBMC model, this platform can simulate not only the growth and spread of tumors but also delve deeply into the effects of tumor immunotherapies. This provides a comprehensive and realistic simulation environment for your immunotherapy research.
Our systemic inoculation platform for hematologic tumor research integrates a multitude of cutting-edge techniques, aiming to offer robust support for your hematologic tumor drug and immunotherapy development. Should you have any questions or require further insights, please don't hesitate to contact us.
- Tel 15010000264
- E-mail limy@imodels.tech
- Tel 13810723384
- Top
InnoModels Biotechnology (Beijing) Co., Ltd.
TEL:15010000264 13810723384
Email:cndw@imodels.tec
Address:Building 14, Life Valley, Shuangying West Road, Changping District, Beijing
Chuangmo Biotechnology (Beijing) Co., Ltd. Beijing ICP 222*** 98-1 Website Construction: China Enterprise Power Beijing Second Branch Company